Clinical Features, Differential Diagnosis and Treatment of IgG4-Related Sclerosing Cholangitis
Архивъ внутренней медициныThe aim: To present the state-of-the-art of clinical features, differential diagnosis and treatment of IgG4-related sclerosing cholangitis.Key points: IgG4-sclerosing cholangitis is a fibrotic inflammatory disease affecting the intrahepatic and ...
A. K. Guseva, A. V. Okhlobystin
doaj +2 more sources
IgG4-related sclerosing cholangitis
Annals of Hepatology, 2011 Terumi Kamisawa, Taku Tabata
doaj +3 more sources
Cholangiocarcinoma Resembling IgG4-related Sclerosing Cholangitis. [PDF]
Intern Med, 2023 A 66-year-old man diagnosed with immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) with diffuse intrahepatic bile duct stenosis and elevated serum IgG4 levels was referred for a further examination because of elevated serum carbohydrate antigen 19-9 levels despite treatment with corticosteroids.
Akahoshi K +10 more
europepmc +3 more sources
IgG4-Related Sclerosing Cholangitis: A Clinical and Imaging Review
American Journal of Roentgenology, 2019 OBJECTIVE. The purpose of this article is to present the pathologic and clinical features of IgG4-related sclerosing cholangitis (ISC), illustrate the associated imaging findings, and discuss treatment of the disorder. CONCLUSION.
Das, Prasenjit +4 more
core +3 more sources
IgG4-related sclerosing cholangitis mimicking cholangiocarcinoma. [PDF]
J Surg Case Rep, 2023 Abstract A man in his 70s presented to the emergency department with painless obstructive jaundice. Initial blood test results show a predominantly cholestatic picture with elevated tumour markers, and imaging findings are concerning for a pancreatic head neoplasm or cholangiocarcinoma with involvement of the entire common bile duct. The
Ng WR, Lau NS, Fadia M, Gananadha S.
europepmc +3 more sources
Innovative Surgical Sciences, 2018 Even though IgG4-related disease has gained increased attention worldwide, the diagnosis remains challenging. IgG4-related sclerosing cholangitis (IgG4-SC) is not well described in the western hemisphere and may mimic cholangiocarcinoma (CC), especially ...
Mittelstaedt Anke +4 more
doaj +2 more sources
A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis. [PDF]
Liver Int, 2022 BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) and IgG4‐related sclerosing cholangitis (IgG4‐SC) are chronic fibro‐inflammatory immune‐mediated hepatobiliary conditions that are challenging to distinguish in a clinical setting.
Radford-Smith DE +11 more
europepmc +2 more sources
IgG4-related sclerosing cholangitis. [PDF]
Clin Liver Dis (Hoboken), 2017 Culver EL, Barnes E.
europepmc +5 more sources
Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report. [PDF]
Am J Case Rep, 2022 Patient: Male, 70-year-old Final Diagnosis: Drug induced hepatopathy • gangrenous cholecystitis • IgG4 related sclerosing cholangitis • systemic IgG4 related disease Symptoms: Abdominal pain • jaundice Medication: — Clinical Procedure: Computed ...
Gummlich BPM +2 more
europepmc +2 more sources
Epigenetic age acceleration and methylation differences in IgG4-related cholangitis and primary sclerosing cholangitis [PDF]
Clinical EpigeneticsBackground IgG4-related cholangitis (IgG4-SC) and primary sclerosing cholangitis (PSC) are chronic fibro-inflammatory hepatobiliary conditions, with genetic, environmental, and immunologic risk factors, in which epigenetic alterations may provide ...
Alexandra Noble +8 more
doaj +2 more sources